TY - JOUR AU - Li, Wenjun AU - Feng, Guoshuai AU - Gauthier, Jason M. AU - Lokshina, Inessa AU - Higashikubo, Ryuji AU - Evans, Sarah AU - Liu, Xinping AU - Hassan, Adil AU - Tanaka, Satona AU - Cicka, Markus AU - Hsiao, Hsi-Min AU - Ruiz-Perez, Daniel AU - Bredemeyer, Andrea AU - Gross, Richard W. AU - Mann, Douglas L. AU - Tyurina, Yulia Y. AU - Gelman, Andrew E. AU - Kagan, Valerian E. AU - Linkermann, Andreas AU - Lavine, Kory J. AU - Kreisel, Daniel T1 - Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation PY - 2019/06/03/ AB - Nonapoptotic forms of cell death can trigger sterile inflammation through the release of damage-associated molecular patterns, which are recognized by innate immune receptors. However, despite years of investigation, the mechanisms that initiate inflammatory responses after heart transplantation remain elusive. Here, we demonstrate that ferrostatin-1 (Fer-1), a specific inhibitor of ferroptosis, decreases the levels of pro-ferroptotic hydroperoxy-arachidonoyl-phosphatidylethanolamine, reduces cardiomyocyte cell death, and blocks neutrophil recruitment following heart transplantation. Inhibition of necroptosis had no effect on neutrophil trafficking in cardiac grafts. We extend these observations to a model of coronary artery ligation–induced myocardial ischemia reperfusion injury (IRI), in which inhibition of ferroptosis resulted in reduced infarct size, improved left ventricular (LV) systolic function, and reduced LV remodeling. Using intravital imaging of cardiac transplants, we show that ferroptosis orchestrates neutrophil recruitment to injured myocardium by promoting adhesion of neutrophils to coronary vascular endothelial cells through a TLR4/Trif/type I IFN signaling pathway. Thus, we have discovered that inflammatory responses after cardiac transplantation are initiated through ferroptotic cell death and TLR4/Trif-dependent signaling in graft endothelial cells. These findings provide a platform for the development of therapeutic strategies for heart transplant recipients and patients who are vulnerable to IRI following restoration of coronary blood flow. JF - The Journal of Clinical Investigation JA - J Clin Invest SN - 0021-9738 DO - 10.1172/JCI126428 VL - 129 IS - 6 UR - https://doi.org/10.1172/JCI126428 SP - 2293 EP - 2304 PB - The American Society for Clinical Investigation ER -